Literature DB >> 2865003

Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth.

D J Grdina, C Peraino, B A Carnes, C K Hill.   

Abstract

We have investigated the protective effects of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721) on the induction by radiation of altered hepatocyte foci in 150-day-old Sprague-Dawley rats. WR2721 (100 micrograms/g of body weight) was administered to selected groups of neonatal animals 30 min prior to the administration of single doses of ionizing radiation (150 or 300 rads). Two focus phenotypes, described by the histochemical markers gamma-glutamyltranspeptidase and iron exclusion, were quantitated through the use of serial frozen sectioning techniques and computer-assisted image analysis. Although radiation was capable of inducing foci, induction was much more effective in female than in male rats. WR2721, however, reduced the frequencies of radiation-induced foci at both radiation doses, with the protective effect more readily apparent in female animals. The modulation of foci formation by WR2721 in the neonatal rat system suggests that this compound and related aminothiols may be useful probes for examining mechanisms of mutagenesis and carcinogenesis induced by radiation or chemicals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

Review 2.  Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome.

Authors:  C R Culy; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

Review 4.  Iron, radiation, and cancer.

Authors:  R G Stevens; D R Kalkwarf
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

5.  The effect of 2-[(aminopropyl)amino] ethanethiol on fission-neutron-induced DNA damage and repair.

Authors:  D J Grdina; C P Sigdestad; P J Dale; J M Perrin
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

6.  The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cells.

Authors:  D J Grdina; B Nagy
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.